Dr. Robert A. Nagourney, MD
Toward A 100% Response Rate in Human Cancer
Oncologists confront numerous hurdles as they attempt to apply the new cancer prognostic and predictive tests. Among them are the...
top of page
Cancer Blog
- Dr. Robert Nagourney -
Search
Dr. Robert A. Nagourney, MD
Aug 5, 20143 min read
Cancer Centers and Advertising: The Truth Be Told
Some of the most interesting literature on cancer comes from journals that are not directly involved in the field. I was reminded of this...
Dr. Robert A. Nagourney, MD
Jul 30, 20143 min read
With an EVA-PCD Assay, It Can Be That Simple - End Stage CLL Success
Shortly after I left the university and joined a medical oncology group, one of the junior members of the practice asked if I would cover...
Dr. Robert A. Nagourney, MD
Jul 22, 20143 min read
The Changing Landscape in Non-small Cell Lung Cancer (NSCLC)
In October 2012, we published a study of patients with metastatic NSCLC whose treatment was guided by ourEVA-PCD laboratory analysis. The...
Dr. Robert A. Nagourney, MD
Jul 8, 20142 min read
With Cancer, Don’t Ask the Experts - A View from the Outside
I was recently provided a video link to a December 2013 TEDx conference presentation entitled, "Big Data Meets Cancer" by Neil Hunt,...
Dr. Robert A. Nagourney, MD
Jul 2, 20142 min read
Truly Personalized Cancer Therapy
In the mid 1980s, it became apparent to me that cancer did not result from uncontrolled cell proliferation, but instead from the lack of...
Dr. Robert A. Nagourney, MD
Jun 26, 20142 min read
Frustrating Reality – When a Tumor Sample is Insufficient for Testing
A dying leukemia cell. The principles underlying the Rational Therapeutics EVA-PCD platform reflect many years of development. ...
Dr. Robert A. Nagourney, MD
Jun 17, 20143 min read
What is Cancer Research?
According to Wikipedia, cancer research is “basic research into cancer in order to identify causes and develop strategies for prevention,...
Dr. Robert A. Nagourney, MD
Jun 11, 20143 min read
The Rising Cost of Cancer Research: Is It Necessary?
For anyone engaged in developmental therapeutics and for those patients who need new approaches to their cancers, an editorial in the...
Dr. Robert A. Nagourney, MD
May 28, 20143 min read
What is Meaningful Improvement in Lung Cancer? A Look at NSCLC Data
When asked to define what constituted pornography in his 1964 Supreme Court decision (Jacobellis versus Ohio 1964) Justice Potter Stewart...
Dr. Robert A. Nagourney, MD
May 19, 20144 min read
Every Cancer Patient Outcome is Important - Stage 4 Stomach Cancer
Clinical oncologists can be divided into different camps. There are those who see patient outcomes as a means-to-an-end. Each clinical...
Dr. Robert A. Nagourney, MD
May 4, 20145 min read
Cancer Patient’s Need to Know – Whose Avatar is it?
The 1984 celebrated case of Baby Fae described the efforts of intrepid investigators at Loma Linda University in California to save the...
Dr. Robert A. Nagourney, MD
Apr 14, 20142 min read
Stage IV NSCLC Patient From the VA Outlives Hospice
For those of you who have read my book Outliving Cancer you will recognize the chapter entitled “Outliving Hospice.” It is the...
Dr. Robert A. Nagourney, MD
Apr 8, 20142 min read
Breast Cancer-Same Age, Same Diagnosis, Different Functional Profiles
A day in the life of advanced breast cancer. Two different 37-year-old breast cancer patients, both mothers of young children, were seen...
Dr. Robert A. Nagourney, MD
Apr 1, 20143 min read
Why Do Cancer Surgeons Cure More Patients Than Medical Oncologists?
Surgery remains the most curative form of cancer treatment. While the reasons for this are many, the most obvious being earlier stage of...
Dr. Robert A. Nagourney, MD
Mar 26, 20142 min read
Cancer Medicine – A Humbling Experience
In his brilliant 1998 book, Consilience, Edward O. Wilson, notes: “The cost of scientific advance is the humbling recognition that...
Dr. Robert A. Nagourney, MD
Mar 25, 20143 min read
Is It Ethical to Deny Cancer Patients Functional Analyses?
The ethical standards that govern human experimentation have become an important topic of discussion. Clinical trials are conducted to...
Dr. Robert A. Nagourney, MD
Mar 10, 20143 min read
Triple Negative Breast Cancer - Worse or Just Different?
The term “triple negative breast cancer” (TNBC) is applied to a subtype of breast cancers that do not express the estrogen or...
Dr. Robert A. Nagourney, MD
Mar 4, 20144 min read
Mammography – The Evolving Story of a Cancer Diagnostic Tool
The use of low-dose radiation to detect occult breast malignancies can be traced to work done at the MD Anderson Cancer Center in the...
Dr. Robert A. Nagourney, MD
Feb 27, 20143 min read
Barretos Cancer Center of Brazil – The Asymmetric War On Cancer
I recently returned from a lecture tour at the Barretos Cancer Center of Brazil located 300 miles from Sao Paulo. This cancer center,...
bottom of page